| Product Code: ETC6207723 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Austria Neuraminidase Inhibitors Market Overview |
3.1 Austria Country Macro Economic Indicators |
3.2 Austria Neuraminidase Inhibitors Market Revenues & Volume, 2021 & 2031F |
3.3 Austria Neuraminidase Inhibitors Market - Industry Life Cycle |
3.4 Austria Neuraminidase Inhibitors Market - Porter's Five Forces |
3.5 Austria Neuraminidase Inhibitors Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Austria Neuraminidase Inhibitors Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Austria Neuraminidase Inhibitors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Austria Neuraminidase Inhibitors Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Austria Neuraminidase Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Austria Neuraminidase Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of influenza in Austria |
4.2.2 Growing awareness about the importance of early treatment of influenza |
4.2.3 Rising government initiatives to promote vaccination programs |
4.3 Market Restraints |
4.3.1 High cost associated with neuraminidase inhibitors |
4.3.2 Potential side effects and safety concerns of the medications |
4.3.3 Competition from alternative treatments for influenza |
5 Austria Neuraminidase Inhibitors Market Trends |
6 Austria Neuraminidase Inhibitors Market, By Types |
6.1 Austria Neuraminidase Inhibitors Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Austria Neuraminidase Inhibitors Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Austria Neuraminidase Inhibitors Market Revenues & Volume, By Influenza Virus Type A, 2021- 2031F |
6.1.4 Austria Neuraminidase Inhibitors Market Revenues & Volume, By Influenza Virus Type B, 2021- 2031F |
6.1.5 Austria Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Austria Neuraminidase Inhibitors Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Austria Neuraminidase Inhibitors Market Revenues & Volume, By Zanamivir, 2021- 2031F |
6.2.3 Austria Neuraminidase Inhibitors Market Revenues & Volume, By Oseltamivir, 2021- 2031F |
6.2.4 Austria Neuraminidase Inhibitors Market Revenues & Volume, By Peramivir, 2021- 2031F |
6.2.5 Austria Neuraminidase Inhibitors Market Revenues & Volume, By Laninamivir, 2021- 2031F |
6.2.6 Austria Neuraminidase Inhibitors Market Revenues & Volume, By Other, 2021- 2031F |
6.3 Austria Neuraminidase Inhibitors Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Austria Neuraminidase Inhibitors Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Austria Neuraminidase Inhibitors Market Revenues & Volume, By Inhalation, 2021- 2031F |
6.3.4 Austria Neuraminidase Inhibitors Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.5 Austria Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Austria Neuraminidase Inhibitors Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Austria Neuraminidase Inhibitors Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Austria Neuraminidase Inhibitors Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Austria Neuraminidase Inhibitors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Austria Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Austria Neuraminidase Inhibitors Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Austria Neuraminidase Inhibitors Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Austria Neuraminidase Inhibitors Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Austria Neuraminidase Inhibitors Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Austria Neuraminidase Inhibitors Market Import-Export Trade Statistics |
7.1 Austria Neuraminidase Inhibitors Market Export to Major Countries |
7.2 Austria Neuraminidase Inhibitors Market Imports from Major Countries |
8 Austria Neuraminidase Inhibitors Market Key Performance Indicators |
8.1 Number of influenza cases reported annually in Austria |
8.2 Percentage of population vaccinated against influenza |
8.3 Frequency of prescriptions for neuraminidase inhibitors |
8.4 Research and development investment in new influenza treatments |
8.5 Patient adherence rate to neuraminidase inhibitor treatment plan |
9 Austria Neuraminidase Inhibitors Market - Opportunity Assessment |
9.1 Austria Neuraminidase Inhibitors Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Austria Neuraminidase Inhibitors Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Austria Neuraminidase Inhibitors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Austria Neuraminidase Inhibitors Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Austria Neuraminidase Inhibitors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Austria Neuraminidase Inhibitors Market - Competitive Landscape |
10.1 Austria Neuraminidase Inhibitors Market Revenue Share, By Companies, 2024 |
10.2 Austria Neuraminidase Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here